Detalhe da pesquisa
1.
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design.
Am J Epidemiol
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061757
2.
Seroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar.
Virol J
; 20(1): 188, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608372
3.
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
Clin Infect Dis
; 75(1): e1188-e1191, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657152
4.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Clin Infect Dis
; 73(7): e1830-e1840, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315061
5.
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
Emerg Infect Dis
; 27(5): 1343-1352, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33900174
6.
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
PLoS Med
; 18(12): e1003879, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914711
7.
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
JAMA
; 326(19): 1930-1939, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724027
8.
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.
Front Med (Lausanne)
; 11: 1363045, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529118
9.
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
Vaccine
; 42(14): 3307-3320, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616439
10.
Prevalence of hepatitis B and C viruses among migrant workers in Qatar.
Sci Rep
; 14(1): 11275, 2024 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760415
11.
Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar.
J Infect Public Health
; 16(2): 250-256, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603377
12.
All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic.
BMJ Glob Health
; 8(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142299
13.
Immediate and contributory causes of death in patients hospitalized with COVID-19.
Int J Infect Dis
; 132: 4-8, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061212
14.
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study.
Lancet Infect Dis
; 23(7): 816-827, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36913963
15.
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study.
EBioMedicine
; 95: 104734, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515986
16.
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study.
Int J Infect Dis
; 136: 81-90, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37717648
17.
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study.
EClinicalMedicine
; 62: 102102, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533414
18.
SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study.
Influenza Other Respir Viruses
; 17(11): e13224, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019700
19.
History of primary-series and booster vaccination and protection against Omicron reinfection.
Sci Adv
; 9(40): eadh0761, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792951
20.
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar.
Int J Infect Dis
; 124: 96-103, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36218031